Targeting Efflux Pumps to Overcome Antifungal Drug Resistance
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Resistance to antifungal drugs is an increasingly significant clinical problem. The most common antifungal resistance encountered is efflux pump-mediated resistance of Candida species to azole drugs. One approach to overcome this resistance is to inhibit the pumps and chemosensitize resistant strains to azole drugs. Drug discovery targeting fungal efflux pumps could thus result in the development of azole-enhancing combination therapy. Heterologous expression of fungal efflux pumps in Saccharomyces cerevisiae provides a versatile system for screening for pump inhibitors. Fungal efflux pumps transport a range of xenobiotics including fluorescent compounds. This enables the use of fluorescence-based detection, as well as growth inhibition assays, in screens to discover compounds targeting efflux-mediated antifungal drug resistance. A variety of medium- and high-throughput screens have been used to identify a number of chemical entities that inhibit fungal efflux pumps.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but that tolerance is not a function of either uptake or efflux rates, despite the well-known role of efflux in drug resistance [65][66][67][68][69] .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [66]
Citations
Cites
1 retracted
Maurya, I. K., Thota, C. K., Verma, S. D., Sharma, J., Rawal, M. K., Ravikumar, B., Sen, S., Chauhan, N., Lynn, A. M., Chauhan, V. S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467159 · Cited by 33
RetractedZhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
The Antimicrobial Resistance Crisis: Causes, Consequences, and Management
Michael, C. A., Dominey-Howes, D., & Labbate, M. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00145 · Cited by 974
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z.-S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2014.11.002 · Cited by 777
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism
Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., & Yamaguchi, A. (2006) · Nature · doi:10.1038/nature05076 · Cited by 773
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Self-citationResistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Research works printed but not linked: 2
- Cannon R SklarLA LindsleyC. Phenotypic HTS multiplex for anti-fungal efflux pump inhibitors. PubChem Bioassay Screening Summary; PubChem AID 485335 (2010). http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=485335.
- Hartland CL , YoungsayeW, DockendorffCet al. Identification of small molecules that selectively inhibit fluconazole-resistant Candida albicans in the presence of fluconazole but not in its absence – Probe 3. In : Probe Reports from the NIH Molecular Libraries Program. Bethesda, MD (2010).
Cited by
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Antifungal Drug Resistance: An Emergent Health Threat
Vitiello, A., Ferrara, F., Boccellino, M., Ponzo, A., Cimmino, C., Comberiati, E., Zovi, A., Clemente, S., & Sabbatucci, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041063 · Cited by 228
Spengler, G., Kincses, A., Gajdács, M., & Amaral, L. (2017) · Molecules · doi:10.3390/molecules22030468 · Cited by 189
Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus
Martinez-Rossi, N. M., Bitencourt, T. A., Peres, N. T. A., Lang, E. A. S., Gomes, E. V., Quaresemin, N. R., Martins, M. P., Lopes, L., & Rossi, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01108 · Cited by 183
The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy
El-Awady, R., Saleh, E., Hashim, A., Soliman, N., Dallah, A., Elrasheed, A., & Elakraa, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00535 · Cited by 162
“…cells by membrane transporters is the most predominant and mutual mechanism of resistance among all organisms (Tillotson and Tillotson, 2010) These membrane transporters are proteins that belong to a superfamily of genes called the ABC (Holmes et al., 2016; Ye et al., 2016; Zhang et al., 2016).”
BackgroundEmerging Antifungal Targets and Strategies
Ivanov, M., Ćirić, A., & Stojković, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052756 · Cited by 160
“Recent reviews have suggested targeting fungal efflux pumps in order to combat drug resistance [49] as well as ergosterol biosynthesis pathway [50].”
BackgroundRole of bacterial efflux pump proteins in antibiotic resistance across microbial species
Kumawat, M., Nabi, B., Daswani, M., Viquar, I., Pal, N., Sharma, P., Tiwari, S., Sarma, D. K., Shubham, S., & Kumar, M. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106182 · Cited by 119
Fungal Drug Response and Antimicrobial Resistance
Osset-Trénor, P., Pascual‐Ahuir, A., & Proft, M. (2023) · Journal of Fungi · doi:10.3390/jof9050565 · Cited by 117
Targeting antimicrobial drug resistance with marine natural products
Barbosa, F., Pinto, E., Kijjoa, A., Pinto, M. M. M., & Sousa, E. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106005 · Cited by 103
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi
Hokken, M., Zwaan, B. J., Melchers, W. J. G., & Verweij, P. E. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103254 · Cited by 110
“, 2014) and blocking these transporters reduces the MICs significantly (Holmes et al., 2016).”
BackgroundFungal keratitis: Mechanisms of infection and management strategies
Donovan, C. P., Arenas, E., Ayyala, R. S., Margo, C. E., & Espana, E. M. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.08.002 · Cited by 97
Iyer, K. R., Camara, K., Daniel-Ivad, M., Trilles, R., Pimentel-Elardo, S. M., Fossen, J. L., Marchillo, K., Liu, Z., Singh, S., Muñoz, J. F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20183-3 · Cited by 72
Assress, H. A., Selvarajan, R., Nyoni, H. H., Mamba, B. B., & Msagati, T. A. M. (2021) · Reviews in Environmental Science and Bio/Technology · doi:10.1007/s11157-021-09594-w · Cited by 73
“…cyp51A gene in Aspergillus niger and Aspergillus tubingensis isolates (Hashimoto et al. 2017) and mutation at G427S and K97T in cyp51A gene of Aspergillus niger have been suggested warranting further study to understand the complete molecular mechanisms (Howard et al. 2011; Rajendran et al. 2016).”
BackgroundMechanisms of Action of Flavonoids: Antioxidant, Antibacterial and Antifungal Properties
Rodríguez, B., Pacheco, L. G. C., Bernal, I., & Piña, M. (2023) · Ciencia Ambiente y Clima · doi:10.22206/cac.2023.v6i2.3021 · Cited by 67
“ATP-binding cassette, for instance, a family of efflux pump proteins composed of nucleotide binding domains (NBD) aim to break down ATP to transport substances out of the cell (Holmes et al., 2016).”
BackgroundCairns, T. C., Zheng, X., Zheng, P., Sun, J., & Meyer, V. (2021) · Journal of Fungi · doi:10.3390/jof7070535 · Cited by 72
“Heterologous expression of efflux pump encoding genes is an attractive option compared to assays using clinical isolates, as the latter strains may possess multiple mechanism of antifungal resistance (reviewed in [243]).”
BackgroundZhang, C.-W., Zhong, X., Zhao, Y.-S., Rajoka, M. S. R., Hashmi, M. H., Zhai, P. C., & Song, X. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100262 · Cited by 72
Multidrug transporters of Candida species in clinical azole resistance
Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 57
Ramzan, M., Gourion‐Arsiquaud, S., Hussain, A., Gulati, J. S., Zhang, Q., Trehan, S., Puri, V., Michniak‐Kohn, B. B., & Kaur, I. P. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01058-6 · Cited by 62
“Most fungal cells have specialized efflux system resulting in frequent drug resistance [5].”
BackgroundPotential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review
Rabaan, A. A., Sulaiman, T., Al-Ahmed, S. H., Buhaliqah, Z. A., Buhaliqah, A. A., AlYuosof, B., Alfaresi, M. S., Fares, M. A. A., Alwarthan, S. M., Alkathlan, M. S., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12030608 · Cited by 66
“albicans, CDR1 and CDR2 are two promiscuous ABC proteins that are upregulated [116,117].”
BackgroundAntimicrobial Peptides: Virulence and Resistance Modulation in Gram-Negative Bacteria
Duperthuy, M. (2020) · Microorganisms · doi:10.3390/microorganisms8020280 · Cited by 58
Jia, D., & Sun, W. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104937 · Cited by 58
Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 58
“There are several excellent earlier reviews that have considered aspects of azole synergy [52,102,103]; here we provide an update with a particular focus on developments made over the past six years.”
BackgroundSilva-Beltrán, N. P., Boon, S., Ijaz, M. K., McKinney, J., & Gerba, C. P. (2023) · Journal of Industrial Microbiology & Biotechnology · doi:10.1093/jimb/kuad036 · Cited by 66
Samaras, Α., Ντάσιου, Π., Myresiotis, C. K., & Karaoglanidis, G. S. (2020) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2020.108896 · Cited by 59
Ahmad, A., Wani, M. Y., Patel, M., SOBRAL, A. J. F. N., Duse, A. G., Aqlan, F. M., & Al‐Bogami, A. S. (2017) · MedChemComm · doi:10.1039/c7md00440k · Cited by 51
Song, J., Zhou, J., Zhang, L., & Li, R. (2020) · Microorganisms · doi:10.3390/microorganisms8101574 · Cited by 51
“pathogenic fungi [32,33], little is known about the molecular pathways involved in the regulation of”
BackgroundWu, M., Xu, X., Hu, R. M., Chen, Q., Chen, L., Yuan, Y., Li, J., Zhou, L., Feng, S., Wang, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202207736 · Cited by 50
Host-Pathogen Interactions Mediated by MDR Transporters in Fungi: As Pleiotropic as it Gets!
Cavalheiro, M., Pais, P., Galocha, M., & Teixeira, M. C. (2018) · Genes · doi:10.3390/genes9070332 · Cited by 47
“A subset of these transporters is involved in drug efflux [36].”
BackgroundStanford, F. A., & Voigt, K. (2020) · Genes · doi:10.3390/genes11111296 · Cited by 46
Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?
Demuyser, L., & Dijck, P. V. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.02.002 · Cited by 46
Sensitization and synergistic anti-cancer effects of Furanodiene identified in zebrafish models
Zhu, X., Guo, D., Lao, Q., Xu, Y.-Q., Meng, Z.-K., Xia, B., Yang, H. Q., Li, C., & Li, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-40866-2 · Cited by 42
Jindal, S., Yang, L., Day, P. J., & Kell, D. B. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1561-0 · Cited by 42
Pianalto, K. M., Billmyre, R. B., Telzrow, C. L., & Alspaugh, J. A. (2019) · Genetics · doi:10.1534/genetics.119.302290 · Cited by 41
Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles
Elias, R., Basu, P., & Fridman, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01807 · Cited by 40
Winski, C. J., Qian, Y., Mobashery, S., & Santiago-Tirado, F. H. (2022) · mBio · doi:10.1128/mbio.01539-22 · Cited by 37
“the overexpression of ABC efflux pumps has been implicated in FLC resistance (21).”
BackgroundAn insight into new strategies to combat antifungal drug resistance
Zheng, Y., Ma, Y., Ding, Y., Chen, X., & Gao, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s185833 · Cited by 37
Li, X., Zhao, Y., Huang, X., Yu, C., Yang, Y., & Sun, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00124 · Cited by 35
“Two main classes of drug transport pumps are responsible for the development of antifungal resistance: ATP-binding cassette transporters and major facilitator superfamily transporters (Holmes et al., 2016).”
BackgroundSamee, A., Usman, F., Wani, T. A., Farooq, M., Shah, H. S., Javed, I., Ahmad, H. A., Khan, R., Zargar, S., & Kausar, S. (2023) · Molecules · doi:10.3390/molecules28227508 · Cited by 35
“Most fungal infections are found in the lower epidermal (stratum basale layer), superficial area and vel-lus hairs as fungal cells have a specific efflux mechanism that results in drug resistance [10].”
BackgroundGeraniol eradicates Candida glabrata biofilm by targeting multiple cellular pathways
Gupta, P., Gupta, H., & Poluri, K. M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11397-6 · Cited by 40
Alqahtani, M. J., Elekhnawy, E., Negm, W. A., Mahgoub, S., & Hussein, I. A. (2022) · Journal of Fungi · doi:10.3390/jof8050521 · Cited by 33
“Efflux pumps are a common cause of fungi resistance to antifungals, and they are encoded by different genes [3].”
BackgroundTranscriptome Signatures Predict Phenotypic Variations of Candida auris
Jenull, S., Tscherner, M., Kashko, N., Shivarathri, R., Stoiber, A., Chauhan, M., Petryshyn, A., Chauhan, N., & Kuchler, K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.662563 · Cited by 32
Molecular mechanisms that govern infection and antifungal resistance in Mucorales
Lax, C., Nicolás, F. E., Navarro, E., & Garre, V. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00188-22 · Cited by 35
Xu, J., Liu, R., Sun, F., An, L., Shang, Z., Kong, L., & Yang, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00211 · Cited by 35
A Comparative Review of Eugenol and Citral Anticandidal Mechanisms: Partners in Crimes Against Fungi
Shahina, Z., & Dahms, T. E. S. (2024) · Molecules · doi:10.3390/molecules29235536 · Cited by 34
“Consequentially mitochondria influence the yeast-to-hyphal morphological transition, cell wall biogenesis, virulence, and antifungal resistance [62], and are therefore a target for antifungal development [63,64].”
Banerjee, A., Pata, J., Sharma, S., Monk, B. C., Falson, P., & Prasad, R. (2021) · Journal of Fungi · doi:10.3390/jof7020068 · Cited by 34
Self-citationKigen, G., & Edwards, G. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0129-6 · Cited by 29
Nagy, G., Kiss, S. A., Varghese, R., Bauer, K., Szebenyi, C., Kocsubé́, S., Homa, M., Bodai, L., Zsindely, N., Nagy, G., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.660347 · Cited by 30
“Expression of drug efflux pumps, which belong to the ATPbinding cassette (ABC) or the major facilitator superfamily (MFS) transporters, was found to a major factor contributing in the fungal resistance to azoles in several human pathogenic fungi (Prasad and Rawal, 2014; Holmes et al., 2016; Lopez-Ribot et al., 2017; S…”
BackgroundRecent progress on anti-Candida natural products
Sun, F., Li, M., Liang, G. U., Wang, M., & Yang, M. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60057-2 · Cited by 31
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
Pour, S. T. A., Orré, C., Bertevello, P. S., Mirebeau‐Prunier, D., Dumas, J., & Desquiret‐Dumas, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115897 · Cited by 27
Williams, C. C., Gregory, J., & Usher, J. (2024) · Microbiology · doi:10.1099/mic.0.001512 · Cited by 26
“Azole-resistant A. fumigatus strains can also upregulate efflux pumps ~5–30-fold [127], decreasing intracellular azole accumulation [128].”
BackgroundNew diphenylphosphane derivatives of ketoconazole are promising antifungal agents
de Almeida, R. F. M., Santos, F. C., Marycz, K., Alicka, M., Krasowska, A., Suchodolski, J., Panek, J. J., Jezierska, A., & Starosta, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-52525-7 · Cited by 25
Cordeiro, R. D. A., Portela, F. V. M., Pereira, L. M., de Andrade, A. R. C., de Sousa, J. K., Aguiar, A. L. R., Pergentino, M. L. M., Sales, G., de Oliveira, J. S., Medrano, D. J. A., et al. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0186 · Cited by 26
Mutations in Cyp51 of Venturia inaequalis and their effects on DMI sensitivity
Hoffmeister, M., Zito, R., Böhm, J., & Stammler, G. (2021) · Journal of Plant Diseases and Protection · doi:10.1007/s41348-021-00516-0 · Cited by 21
Recent advances in high-throughput flow cytometry for drug discovery
Ding, M., & Baker, D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1826433 · Cited by 21
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Novel avenues for identification of new antifungal drugs and current challenges
Jampílek, J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2097659 · Cited by 22
Zhang, Y., He, K., Guo, X., Jiang, J., Qian, L., Xu, J., Che, Z., Huang, X., & Liu, S. (2023) · Journal of Fungi · doi:10.3390/jof9030334 · Cited by 20
“Three ABC transports related to multidrug resistance in Botrytis cinereal, Bcatrab [34,39], BcatrD, and BcatrK [40], exhibited varied sensitivities to different drugs after the knockout.”
BackgroundAzole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris
Toepfer, S., Keniya, M. V., Lackner, M., & Monk, B. C. (2024) · Journal of Fungi · doi:10.3390/jof10100698 · Cited by 23
“Better efficacy due to the involvement of multiple targets theoretically reduces the risk of resistance development, and potentially increases the economic life span of antifungal drugs [26], e.g., by repurposing existing drugs [27].”
BackgroundSelf-citationAneke, C. I., Rhimi, W., Otranto, D., & Cafarchia, C. (2020) · Mycopathologia · doi:10.1007/s11046-019-00419-7 · Cited by 19
Gil, F., Laiolo, J., Bayona-Pacheco, B. L., Cannon, R. D., Ferreira‐Pereira, A., & Carpinella, M. C. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03745-4 · Cited by 19
Self-citationSchwarz, P., & Dannaoui, É. (2020) · Journal of Fungi · doi:10.3390/jof6030103 · Cited by 19
“As tacrolimus is a known inhibitor of efflux pumps [44], it could be speculated that synergy may be more frequent in azole-resistant strains with an overexpression of efflux pumps.”
BackgroundMarena, G. D., Ramos, M. A. D. S., Carvalho, G. C., Paris, J. A., Resende, F. A., Corrêa, I., Ono, G. Y. B., Araújo, V. H. S., de Camargo, B. A. F., Bauab, T. M., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7460 · Cited by 20
Sousa, I. S., de Mello, T. P., Paiva-Pereira, E., Granato, M. Q., Alviano, C. S., dos Santos, A. L. S., & Kneipp, L. F. (2022) · Journal of Fungi · doi:10.3390/jof8090963 · Cited by 20
“The efflux pumps that mediate the antifungal resistance are frequently related to the transmembrane transporter, especially the ATP-binding cassette (ABC) transporter family [37,38].”
BackgroundBiochemical and metabolomic insights into antifungal mechanism of berberine against Candida glabrata
Gupta, P., Gupta, H., Tripathi, S., & Poluri, K. M. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12714-x · Cited by 17
Wang, T., Shi, X., Wu, Z., Zhang, J., Hao, J. J., Liu, P., & Liu, X. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c02409 · Cited by 16
Elgammal, Y., Salama, E. A., & Seleem, M. N. (2023) · Medical Mycology · doi:10.1093/mmy/myad081 · Cited by 16
Efflux, Signaling and Warfare in a Polymicrobial World
Moore-Machacek, A., Gloe, A., O’Leary, N. D., & Reen, F. J. (2023) · Antibiotics · doi:10.3390/antibiotics12040731 · Cited by 14
Arifuzzaman, M., Mitra, S., Jahan, S. I., Jakaria, M., Abeda, T., Absar, N., & Dash, R. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.07.012 · Cited by 14
de Moraes, D. C., Cardoso, K. M., Domingos, L. T. S., Pinto, M. D. C. F. R., Monteiro, R. Q., & Ferreira‐Pereira, A. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00254-9 · Cited by 17
Zeitoun, H., Salem, R. A., Guink, N. E., Tolba, N. S., & Mohamed, N. M. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03512-0 · Cited by 11
“Apart from mechanisms involving the ergosterol biosynthetic pathway, the efflux of the antifungal agent is considered the most common cause of FLC resistance in Candida [18].”
BackgroundTripathi, A., Giri, V. P., Pandey, S., Chauhan, P., Kumar, N., Verma, P., Tiwari, V., Verma, P., & Mishra, A. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107041 · Cited by 11
Small molecule II-6s synergises with fluconazole against Candida albicans
Yang, S., Peng, X., Ren, B., Luo, Y., & Xu, X. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106820 · Cited by 11
Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris
Toepfer, S., Lackner, M., Keniya, M. V., Zenz, L.-M., Friemert, M., Bracher, F., & Monk, B. C. (2023) · Journal of Fungi · doi:10.3390/jof9060663 · Cited by 11
Self-citationComprehensive insights into the role of nanocarriers in advancing azole-based ocular therapeutics
Sil, D., Ghosh, R., Kumar, D., Taha, M., Alaseem, A. M., Elhassan, G. O., Kumar, M., & Mujtaba, M. A. (2025) · RSC Advances · doi:10.1039/d5ra04608d · Cited by 10
Natural Source-Derived Compounds with Antifungal Activity Against Medically Relevant Fungi
Gómez-Gaviria, M., Baruch-Martínez, D. A., & Mora-Montes, H. M. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s554647 · Cited by 10
“24,25 Another key mechanism is biofilm formation, organized structures of fungal cells embedded in an extracellular matrix that protects microorganisms from attack by antifungal agents and the host immune response.”
A homologous overexpression system to study roles of drug transporters in Candida glabrata
Kumari, S., Kumar, M., Khandelwal, N., Pandey, A. K., Bhakt, P., Kaur, R., Prasad, R., & Gaur, N. A. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa032 · Cited by 9
“glabrata is a culmination of several mechanisms which also includes overexpression of drug efflux pumps belonging to ATP Binding Cassette (ABC) superfamily and Major Facilitator Superfamily (MFS) of transporters which help cells to rapidly extrude antimycotic drugs to circumvent their lethality (Holmes et al. 2016).”
BackgroundFlow Cytometric Measurement of Efflux in Candida Species
Iyer, K. R., Robbins, N., & Cowen, L. E. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.121 · Cited by 9
“Current Protocols in Microbiology, 59, e121. doi: 10.1002/cpmc.121 INTRODUCTION The upregulation of multidrug efflux pumps is a major mechanism of drug resistance among pathogenic fungi (Holmes et al., 2016; Lee, Puumala, Robbins, & Cowen, 2020).”
BackgroundInfluentialYoo, K., Bhattacharya, S., Oliveira, N. K., Pereira de Sa, N., Matos, G. S., Del Poeta, M., & Fries, B. C. (2024) · mBio · doi:10.1128/mbio.01847-24 · Cited by 8
“The ability of Cn cells to produce energy through respiration is crucial for cryptococcal virulence, in vivo resilience, and antifungal resistance (48, 49).”
BackgroundYang, S., Lyu, X., Zhang, J., Shui, Y., Yang, R., & Xu, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.816386 · Cited by 8
Cardoso, B. G., Lima, W. G., Fernandes, S. O. A., de Lima, M. E., & Cardoso, V. N. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2079122 · Cited by 8
“In addition, these drugs have certain disadvantages regarding toxicity, drug interaction, long treatment periods, and the emergence of antifungal resistant isolates (Hope et al. 2013).”
BackgroundPinheiro, A. M., Carreira, A., Prescott, T. A. K., Ferreira, R. B., & Monteiro, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01182 · Cited by 8
Domingos, L. T. S., Santos, M. F. C., de Moraes, D. C., de Sá, L. F. R., da Silva, V. A. D., Meuren, L. M., Berlinck, R. G. S., & Ferreira‐Pereira, A. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104402 · Cited by 8
Jayan, A., & Gupta, S. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2583 · Cited by 7
de Moraes, D. C., de Sá, L. F. R., Domingos, L. T. S., Pinto, M. D. C. F. R., Soares, R. M. D. A., & Ferreira‐Pereira, A. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.09.002 · Cited by 7
Reconstitution of Human Necrosome Interactions in Saccharomyces cerevisiae
Ji, Y., Ward, L. A., & Hawkins, C. J. (2021) · Biomolecules · doi:10.3390/biom11020153 · Cited by 7
“Since P-glycoprotein belongs to an ATP-binding cassette (ABC) sub-family [65], we speculate that yeast ABC family proteins, such as PDR-encoded multidrug resistance transporter [66], may pump dabrafenib out of yeast cells, limiting its intracellular drug concentration in yeast.”
BackgroundKumar, A., Francis, A., Hans, S., & Thakur, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_8 · Cited by 7
Karuga, F. F., Góralska, K., & Brzeziańska‐Lasota, E. (2021) · Acta Mycologica · doi:10.5586/am.566 · Cited by 6
Santi, M. D., Ortega, M. G., & Peralta, M. A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220209103538 · Cited by 6
Harnessing advances in mechanisms, detection, and strategies to combat antimicrobial resistance
Thakur, R., Aggarwal, K., Sood, N., Kumar, A., Joshi, S., Jindal, P., Maurya, R., Patel, P., & Kurmi, B. D. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.179641 · Cited by 5
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses
Bilal, Z., Tipping, W. J., Brown, J. L., & Faulds, K. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2555937 · Cited by 7
“…upregulation of ABc transporters has also been found to positively correlate with fungal biofilm development, particularly in Candida albicans (Soto 2013). to this end, efflux pumps provide promising targets for overcoming antifungal drug resistance (Holmes et al. 2016; engle and Kumar 2024).”
Mechanisms Of Dermatophyte Resistance To Antifungal Substances
Łagowski, D., Gnat, S., & Nowakiewicz, A. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.2.012 · Cited by 7
RetractedPluronic F-127 Enhances the Antifungal Activity of Fluconazole against Resistant Candida Strains
Malec, K., Mikołajczyk, A., Marciniak, D. M., Gawin-Mikołajewicz, A., Matera-Witkiewicz, A., Karolewicz, B., Nawrot, U., Khimyak, Y. Z., & Nartowski, K. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00536 · Cited by 5
Mechanisms of antifungal resistance
Delgado, J., Núñez, F., Bermúdez, E., & Asensio, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00156-8 · Cited by 7
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence
Yehia, F. A. A., Abbas, H. A., Ibrahim, T. M., Mansour, B., Awan, Z. A., Al-Rabia, M. W., Abdulaal, W. H., Zeyadi, M., Okbazghi, S. Z., Ibrahim, T. S., et al. (2025) · AMB Express · doi:10.1186/s13568-025-01824-6 · Cited by 5
Dose-Dependent Genetic Resistance to Azole Fungicides Found in the Apple Scab Pathogen
Heaven, T., Armitage, A. D., Xu, X., Goddard, M. R., & Cockerton, H. M. (2023) · Journal of Fungi · doi:10.3390/jof9121136 · Cited by 5
“As such, similar mechanisms should also be considered for genes in the vicinity of the LG1 and LG7 QTLs.”
Backgroundda Silva, A. R., Raposo, B. L., de Lima, G. S., Bueno-Janice, J. C., Sellera, F. P., Filho, P. E. C., Fontes, A. M., & Ribeiro, M. S. (2025) · BioNanoScience · doi:10.1007/s12668-025-01932-4 · Cited by 4
“Key resistance mechanisms include the upregulation of drug efflux pumps, such as ABC and MFS transporters, which actively expel antifungal drugs from the cell, thereby reducing their efficacy [31].”
Molecular Strategies to Overcome Fungal Virulence in Crop Protection
Molina‐Santiago, C., & Vela‐Corcía, D. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70220 · Cited by 4
“This approach offers a complementary strategy to manage resistance and enhance the efficacy of existing fungicidal treatments (Cannon et al. 2009; Holmes et al. 2016; Hu and Chen 2021).”
Zhang, C., Liu, J., Jiang, Y. N., & Sun, S. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01520-25 · Cited by 6
“The resistance of C. albicans to azole antifungals, such as FLC, is frequently associ ated with enhanced efflux pump activity (45).”
Golafshani, F. Z. R., Kermani, F., Godarzi, S. A., & Omran, S. M. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70123 · Cited by 4
Fungal plasticity drives adaptation and survival across pathogenic and free-living contexts
Gebreyesus, T. G. (2026) · Discover Life · doi:10.1007/s11084-026-09731-x · Cited by 4
Metadata
- Authors
- Holmes, A. R., Cardno, T. S., Strouse, J. J., Ivnitski-Steele, I., Keniya, M. V., Lackovic, K., Monk, B. C., Sklar, L. A., & Cannon, R. D.
- Affiliations
- University of Otago (NZ)
- The University of Melbourne (AU)
- University of New Mexico (US)
- New Mexico Center for Molecular Discovery, University of New Mexico, Albuquerque, New Mexico, USA
- Corresponding author
- Cannon, Richard D
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2016-07-27
- Volume
- 8
- Issue
- 12
- Pages
- 1485-1501
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- PMC
- PMC5827819
- OpenAlex
- W2478702959
- Cited by
- 156
- References
- 102
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 14 · 2020: 18 · 2019: 10 · 2018: 6 · 2017: 6
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Future Medicinal Chemistry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01-DE016855-01; R03-MH087406-1A1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antifungal resistance, efflux pumps, Candida, chemosensitization, combination therapy, heterologous expression in Saccharomyces cerevisiae, fluorescence-based screening, high-throughput screening, drug discovery
- MeSH terms
- Antifungal Agents, Azoles, Fungi, Humans, Microbial Sensitivity Tests, Mycoses, Drug Resistance, Fungal, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.